HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[A case of synchronous double primary cancers of prostate, and bladder in a hemodialysis patient: a case report].

Abstract
A 60-year-old male, who had been maintained on hemodialysis for 4 years, visited our hospital to receive living renal transplantation. He complained of macrohematuria, and preoperative examination showed elevation of psostate specific antigen (PSA). Cystoscopy revealed papillary tumors on the right lateral bladder wall. Transurethral resection of bladder tumor (TUR-Bt) was performed and histopathological examination showed transitional cell carcinoma, G2, pTa. The histologic diagnosis of the transrectal needle prostate biopsy specimen was moderately differentiated adenocarcinoma. Combined androgen blockade as a neoadjuvant therapy and radical prostatectomy were performed. A case of synchronous double primary cancers, comprised of adenocarcinoma of the prostate and transitional cell carcinoma of the urinary blader in a hemodialysis patient has never been previously reported in the Japanese literature.
AuthorsToyofumi Abe, Tetsuya Hayashi, Jiro Nakayama, Hidefumi Kishikawa, Ken-Ichiro Sekii, Toshiaki Yoshioka, Hiroaki Itatani, Yasuyuki Kojima, Shiro Takahara
JournalHinyokika kiyo. Acta urologica Japonica (Hinyokika Kiyo) Vol. 51 Issue 10 Pg. 689-93 (Oct 2005) ISSN: 0018-1994 [Print] Japan
PMID16285625 (Publication Type: Case Reports, English Abstract, Journal Article, Review)
Topics
  • Adenocarcinoma (diagnosis)
  • Carcinoma, Transitional Cell (diagnosis)
  • Humans
  • Kidney Failure, Chronic (therapy)
  • Male
  • Middle Aged
  • Neoplasms, Multiple Primary
  • Prostatic Neoplasms (diagnosis)
  • Renal Dialysis
  • Urinary Bladder Neoplasms (diagnosis)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: